481 related articles for article (PubMed ID: 25925039)
1. The glomerular permeability factors in idiopathic nephrotic syndrome.
Davin JC
Pediatr Nephrol; 2016 Feb; 31(2):207-15. PubMed ID: 25925039
[TBL] [Abstract][Full Text] [Related]
2. Salvianolic acid A attenuates steroid resistant nephrotic syndrome through suPAR/uPAR-αvβ3 signaling Inhibition.
Li X; Qi D; Wang MY; Ji K; Xie QL; Wang Y; Du SH; Fan HY
J Ethnopharmacol; 2021 Oct; 279():114351. PubMed ID: 34157324
[TBL] [Abstract][Full Text] [Related]
3. "Idiopathic" minimal change nephrotic syndrome: a podocyte mystery nears the end.
Chugh SS; Clement LC
Am J Physiol Renal Physiol; 2023 Dec; 325(6):F685-F694. PubMed ID: 37795536
[TBL] [Abstract][Full Text] [Related]
4. Pathobiochemistry of nephrotic syndrome.
Tesar V; Zima T; Kalousová M
Adv Clin Chem; 2003; 37():173-218. PubMed ID: 12619708
[TBL] [Abstract][Full Text] [Related]
5. Sphingomyelin Phosphodiesterase Acid-Like 3b is Essential for Toll-Like Receptor 3 Signaling in Human Podocytes.
Watanabe S; Hidenori U; Hashimoto S; Riko S; Aizawa T; Tsugawa K; Imaizumi T; Tanaka H
J Membr Biol; 2022 Feb; 255(1):117-122. PubMed ID: 34739556
[TBL] [Abstract][Full Text] [Related]
6. [New findings on the pathogenesis of nephrotic syndrome (review article)].
Tesar V; Zima T; Kalousová M
Sb Lek; 2002; 103(3):379-95. PubMed ID: 12688182
[TBL] [Abstract][Full Text] [Related]
7. ANGPTL4 promotes nephrotic syndrome by downregulating podocyte expression of ACTN4 and podocin.
Li Y; Xu Z; Deng H; Liu M; Lin X; Zhang M; Li G; Yue S; Gao X
Biochem Biophys Res Commun; 2023 Jan; 639():176-182. PubMed ID: 36495766
[TBL] [Abstract][Full Text] [Related]
8. [Minimal change nephrotic syndrome : new insights into disease pathogenesis].
Audard V; Lang P; Sahali D
Med Sci (Paris); 2008 Oct; 24(10):853-8. PubMed ID: 18950582
[TBL] [Abstract][Full Text] [Related]
9. Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.
Yoo TH; Pedigo CE; Guzman J; Correa-Medina M; Wei C; Villarreal R; Mitrofanova A; Leclercq F; Faul C; Li J; Kretzler M; Nelson RG; Lehto M; Forsblom C; Groop PH; Reiser J; Burke GW; Fornoni A; Merscher S
J Am Soc Nephrol; 2015 Jan; 26(1):133-47. PubMed ID: 24925721
[TBL] [Abstract][Full Text] [Related]
10. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome.
Clement LC; Avila-Casado C; Macé C; Soria E; Bakker WW; Kersten S; Chugh SS
Nat Med; 2011 Jan; 17(1):117-22. PubMed ID: 21151138
[TBL] [Abstract][Full Text] [Related]
11. The Rho-GTPase binding protein IQGAP2 is required for the glomerular filtration barrier.
Sugano Y; Lindenmeyer MT; Auberger I; Ziegler U; Segerer S; Cohen CD; Neuhauss SC; Loffing J
Kidney Int; 2015 Nov; 88(5):1047-56. PubMed ID: 26154927
[TBL] [Abstract][Full Text] [Related]
12. Nephrotic syndrome in infants and children: pathophysiology and management.
Downie ML; Gallibois C; Parekh RS; Noone DG
Paediatr Int Child Health; 2017 Nov; 37(4):248-258. PubMed ID: 28914167
[TBL] [Abstract][Full Text] [Related]
13. Podocyte sphingomyelin phosphodiesterase acid-like 3b decreases among children with idiopathic nephrotic syndrome.
Watanabe S; Hirono K; Aizawa T; Tsugawa K; Joh K; Imaizumi T; Tanaka H
Clin Exp Nephrol; 2021 Jan; 25(1):44-51. PubMed ID: 32946006
[TBL] [Abstract][Full Text] [Related]
14. Expression profiling of cultured podocytes exposed to nephrotic plasma reveals intrinsic molecular signatures of nephrotic syndrome.
Panigrahi S; Pardeshi VC; Chandrasekaran K; Neelakandan K; Ps H; Vasudevan A
Clin Exp Pediatr; 2021 Jul; 64(7):355-363. PubMed ID: 33147911
[TBL] [Abstract][Full Text] [Related]
15. Genetics of nephrotic syndrome: new insights into molecules acting at the glomerular filtration barrier.
Zenker M; Machuca E; Antignac C
J Mol Med (Berl); 2009 Sep; 87(9):849-57. PubMed ID: 19649571
[TBL] [Abstract][Full Text] [Related]
16. The Genetics of Nephrotic Syndrome.
Rheault MN; Gbadegesin RA
J Pediatr Genet; 2016 Mar; 5(1):15-24. PubMed ID: 27617138
[TBL] [Abstract][Full Text] [Related]
17. [Role of podocyte injury signaling pathway in steroid-resistant nephrotic syndrome and research progress in traditional Chinese medicine intervention].
Yu WX; Yan W; Dai EL; Tian WX; Dang WJ
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3246-3254. PubMed ID: 37382008
[TBL] [Abstract][Full Text] [Related]
18. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.
Gee HY; Zhang F; Ashraf S; Kohl S; Sadowski CE; Vega-Warner V; Zhou W; Lovric S; Fang H; Nettleton M; Zhu JY; Hoefele J; Weber LT; Podracka L; Boor A; Fehrenbach H; Innis JW; Washburn J; Levy S; Lifton RP; Otto EA; Han Z; Hildebrandt F
J Clin Invest; 2015 Jun; 125(6):2375-84. PubMed ID: 25961457
[TBL] [Abstract][Full Text] [Related]
19. Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome.
Oh J; Reiser J; Mundel P
Pediatr Nephrol; 2004 Feb; 19(2):130-7. PubMed ID: 14673634
[TBL] [Abstract][Full Text] [Related]
20. Foothold of NPHS2 mutations in primary nephrotic syndrome.
Jaffer AT; Ahmed WU; Raju DS; Jahan P
J Postgrad Med; 2011; 57(4):314-20. PubMed ID: 22120861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]